• Dominant vascular/hemodynamic paradigm positions hepatic blood flow and intrahepatic circulation as central to cirrhosis pathophysiology, linking portal hypertension, ascites, and edema [3], [5], [10], [12], [19].

• Diagnostic paradigm foregrounds liver injury biomarkers and biopsy-based assessment, with aspiration biopsy (1939, 1941) and thymol turbidity tests enabling early differentiation of hepatitis, cirrhosis, and recovery [2], [6], [7], [13].

• Natural history and progression framing follows chronic hepatitis and cirrhosis, cholangiolitic forms, and epidemic hepatitides, shaping disease trajectories and therapeutic expectations [4], [8], [9], [15], [16].

• Experimental pathology and animal models provide causal insight into hepatic injury and regeneration, illustrating liver restoration after injury and diet-induced hepatic injury in rats [11], [17].

• Histopathology and morphogenesis emphasize structural changes and pathogenesis of cirrhosis and hepatitis, including morphology-focused analyses and post-epidemic hepatic remodeling [14], [15], [16].